The New York Times Agency May 2010
EN_00914465_1615
(NYT22) HOUSTON -- June 26, 2004 -- DRUGS-MARKETING -- June 26, 2004 -- Dr. Chris Pappas, Director of Clinical Research at St. Luke's Texas Liver Institute, in his office in Houston, Tuesday, June 22, 2004, says Schering-Plough funded "pseudo-trials." At the heart of the various investigations into drug industry marketing is the question of whether drug companies are persuading doctors -- often through payoffs -- to prescribe drugs that patients do not need, or should not use, or for which there may be cheaper alternatives. Investigators are also seeking to determine whether the companies are manipulating prices to cheat the federal Medicaid and Medicare health programs.
CENA MINIMALNA - 100 USD
2004-06-26
EAST NEWS
The New York Times Agency
Michael Stravato/The New York Times/Redux
16463998
0,98MB
25cm x 17cm by 300dpi
2004, 22, 26, ALSO, ALTERNATIVES, AND, ARE, AT, BE, CHEAPER, CHEAT, CHRIS, CLINICAL, COMPANIES, DETERMINE, DIRECTOR, DO, DOCTORS, DR, DRUG, DRUGS, DRUGS-MARKETING, FEDERAL, FOR, FUNDED, HEALTH, HEART, HIS, HOUSTON, IN, INDUSTRY, INSTITUTE, INTO, INVESTIGATIONS, INVESTIGATORS, IS, JUNE, LIVER, LUKE, MANIPULATING, MARKETING, MAY, MEDICAID, MEDICARE, MICHAEL, NEED, NEW, NOT, NYT22, OF, OFFICE, OFTEN, OR, PAPPAS, PATIENTS, PAYOFFS, PERSUADING, PRESCRIBE, PRICES, PROGRAMS, PSEUDO-TRIALS, QUESTION, REDUX, RESEARCH, SAYS, SCHERING-PLOUGH, SEEKING, SHOULD, STRAVATO, TEXAS, THAT, THE, THERE, THROUGH, TIMES, TO, TUESDAY, USE, VARIOUS, WHETHER, WHICH, YORK,